Glaxo’s patent for Zantac’s active ingredient, ranitidine, expired in 1997. That same year, pharmaceutical companies began ...

The lab’s research indicated the drug’s active ingredient, ranitidine, formed NDMA over time or at higher temperatures. The ...

The four being recalled are Zantac 150mg/10ml Syrup ... to quarantine all products which may contain the active pharmaceutical ingredient (API) that is potentially affected by this issue.

In 2020, US regulators pulled Zantac off shelves due to fears that a key ingredient, ranitidine, could turn into a substance that may cause cancer when exposed to heat. That move led to tens of ...

In 2020, US regulators halted the sale of Zantac over concerns that a key ingredient, ranitidine, had the potential to turn into a substance that may trigger cancer when exposed to heat.